Seizure Activity in Alzheimer's Disease

Completed · Not applicable · Has a placebo group

Conditions studied: Alzheimer's Disease, Seizures

In brief

The main purpose of this research project is to study how seizure-like activity affects the blood flow in the brain of patients with Alzheimer's disease (AD). Changes in blood flow can change memory and thinking ability, as happens in Alzheimer's disease. The investigators are using a study drug called Levetiracetam, which helps control seizure-like activity to see if it can help change the abnormal blood flow in the brain that is seen in some people with Alzheimer's disease.

Key facts

Study ID
NCT01554683
Run by
Beth Israel Deaconess Medical Center
People needed
12
Starts
2012-02-01
Expected to finish
2017-07-01
Last updated by the study team
2020-07-23

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.